RE:PHIVIDA VS TINLEYAgree with the other poster. It is the relative or proportional that matters PLUS the number of shares locked up by insiders. Posting raw data as you did below and ending it with why an unrelated company that intends to enter only part of the same market as TNY at some future point is better in the here and now. If VIDA shares were a dime and its market cap therefore adjusted accordingly my response would be I agree with you but in the reality we are forced to live in... your statement that a pure spec play is worth paying a large premium for does not hold water ... at least in the here and now ---
Medicinal wrote: SHARE COUNT
Tinley - 73 million (not diluted)
87 million (diluted)
Phivida - 41 million (not diluted)
53 million (diluted)
Don't even get me started on why Phivida is better.. do I really need too?